title: Prevention of vascular calcification: is pyrophosphate therapy a solution?
abstract: Pyrophosphate, a ubiquitous small-molecule inhibitor of mineralization abundantly present in the extracellular environment, binds to calcium and mineral surfaces to inhibit crystal growth. O'Neill and colleagues show in uremic rats that systemic administration of pyrophosphate prevents or reduces uremia-related vascular calcification, without overt negative consequences for bone and without calcium pyrophosphate deposition disease. These findings prompt further research into the potential of pyrophosphate as treatment for vascular calcification in chronic kidney disease patients.
authors.affiliation: Hugin Mugin Research, Antwerp, Belgium. vpersy@hmresearch.eu
authors.forename: Veerle P
authors.initials: VP
authors.lastname: Persy
authors.forename: Marc D
authors.initials: MD
authors.lastname: McKee
mesh_terms: D000469:Alkaline Phosphatase / Q000235:genetics / Q000502:physiology; D000818:Animals; D002114:Calcinosis / Q000517:prevention & control*; D011756:Diphosphates / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D053495:Osteopontin / Q000502:physiology; D051381:Rats; D014511:Uremia / Q000150:complications*; D014652:Vascular Diseases / Q000517:prevention & control*
chemical_list: D011756:Diphosphates; D053495:Osteopontin; C548267:ALPL protein, human; D000469:Alkaline Phosphatase; C003319:sodium pyrophosphate